Research Integrity: Recent Regulatory Changes and Enforcement Highlights for Academic Medical Centers and Universities
This Briefing is brought to you by AHLA’s Academic Medical Centers and Teaching Hospitals Practice Group.
- May 30, 2025
- Rachel E. Page , Jones Day
In 1981, then-chairman of the Investigations and Oversight Committee of the House Science and Technology Committee, Albert Gore, Jr., held a hearing on research misconduct following public disclosures regarding alleged research misconduct at a number of major research centers. Since then, the issue of research misconduct has been shaped by legislative actions, agency rulemaking, and enforcement efforts. For Academic Medical Centers (AMCs) and other organizations performing research—whether as a sponsor, collaborator, or study site—maintaining high standards of research integrity is not just a matter of ethical responsibility; it is a critical factor in securing and maintaining research funding and promoting public trust in research outcomes and advancements. While this topic is certainly not new, recent enforcement and regulatory activities underscore the importance of implementing appropriate compliance measures to prevent, detect, and address potential misconduct in this area. Specifically, this article discusses recently proposed revisions to regulations promulgated by the Department of Health and Human Services (HHS) relating to research misconduct. It also provides an overview of recent agency and enforcement focus areas, including research result fabrication and concerns regarding foreign interference in research.
ARTICLE TAGS
You must be logged in to access this content.